NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 04:00PM ET
75.95
Dollar change
+1.88
Percentage change
2.54
%
IndexNDX, S&P 500 P/E15.97 EPS (ttm)4.76 Insider Own0.31% Shs Outstand457.84M Perf Week5.52%
Market Cap34.78B Forward P/E16.48 EPS next Y4.61 Insider Trans-0.14% Shs Float456.44M Perf Month7.67%
Enterprise Value41.72B PEG3.00 EPS next Q0.92 Inst Own77.80% Short Float1.40% Perf Quarter-5.90%
Income2.18B P/S1.76 EPS this Y-9.79% Inst Trans-6.66% Short Ratio1.26 Perf Half Y-4.72%
Sales19.80B P/B3.78 EPS next Y13.79% ROA6.64% Short Interest6.39M Perf YTD-2.85%
Book/sh20.07 P/C14.06 EPS next 5Y5.32% ROE26.32% 52W High94.80 -19.88% Perf Year-3.64%
Cash/sh5.40 P/FCF25.31 EPS past 3/5Y-3.96% 5.31% ROIC13.43% 52W Low57.65 31.74% Perf 3Y-
Dividend Est.0.08 (0.11%) EV/EBITDA11.87 Sales past 3/5Y3.81% 3.41% Gross Margin41.57% Volatility2.69% 2.12% Perf 5Y-
Dividend TTM0.13 (0.17%) EV/Sales2.11 EPS Y/Y TTM38.51% Oper. Margin14.88% ATR (14)1.79 Perf 10Y-
Dividend Ex-DateApr 25, 2025 Quick Ratio0.72 Sales Y/Y TTM1.55% Profit Margin11.03% RSI (14)64.56 Recom1.62
Dividend Gr. 3/5Y- - Current Ratio0.94 EPS Q/Q50.81% SMA204.60% Beta1.29 Target Price86.76
Payout2.88% Debt/Eq1.00 Sales Q/Q2.73% SMA507.29% Rel Volume0.64 Prev Close74.07
Employees53000 LT Debt/Eq0.77 EarningsApr 30 BMO SMA200-6.00% Avg Volume5.08M Price75.95
IPODec 15, 2022 Option/ShortYes / Yes EPS/Sales Surpr.10.53% 2.52% Trades Volume3,264,703 Change2.54%
Date Action Analyst Rating Change Price Target Change
May-05-25Upgrade UBS Sell → Neutral $73
Mar-11-25Upgrade Goldman Neutral → Buy $85 → $100
Jan-08-25Upgrade Jefferies Hold → Buy $95 → $103
Sep-26-24Downgrade UBS Neutral → Sell $84 → $74
Sep-18-24Upgrade BTIG Research Neutral → Buy $100
Sep-09-24Initiated JP Morgan Neutral $90
Aug-06-24Initiated Stifel Buy $100
May-30-24Initiated Goldman Neutral $87
Feb-15-24Initiated HSBC Securities Buy $100
Feb-12-24Upgrade UBS Sell → Neutral $66 → $88
Jul-01-25 08:34AM
Jun-25-25 11:40AM
10:03AM
07:40AM
Jun-24-25 02:16PM
10:58AM Loading…
10:58AM
12:02AM
Jun-23-25 08:00AM
Jun-21-25 08:21AM
Jun-20-25 09:11AM
08:25AM
Jun-19-25 12:00PM
Jun-18-25 09:55AM
Jun-16-25 11:19AM
08:30AM
08:46AM Loading…
Jun-12-25 08:46AM
Jun-06-25 11:31AM
Jun-04-25 09:34PM
08:41AM
Jun-02-25 08:00AM
May-30-25 09:20AM
May-22-25 04:40PM
May-16-25 01:48PM
11:59AM
10:12AM
May-15-25 10:51AM
08:00AM
May-14-25 09:14AM
May-13-25 05:35PM
09:26AM
09:00AM Loading…
09:00AM
08:00AM
May-12-25 02:12PM
08:00AM
May-08-25 05:58PM
04:11PM
May-06-25 09:10AM
May-05-25 05:46PM
03:00PM
12:35PM
08:35AM
12:42AM
May-02-25 09:00AM
May-01-25 12:25AM
Apr-30-25 04:26PM
04:06PM
03:57PM
02:35PM
11:36AM
11:25AM
11:22AM
11:07AM
09:30AM
07:30AM
06:45AM
06:20AM
Apr-29-25 07:00PM
05:40PM
10:54AM
03:09AM
Apr-28-25 11:22AM
09:15AM
08:20AM
Apr-25-25 04:36PM
12:50PM
10:50AM
08:18AM
Apr-24-25 07:10PM
01:30PM
Apr-22-25 07:58PM
Apr-20-25 10:49PM
Apr-17-25 04:01PM
Apr-16-25 02:41PM
Apr-10-25 11:32PM
11:35AM
09:00AM
08:35AM
Apr-09-25 09:00AM
Apr-08-25 01:25PM
Apr-07-25 04:46AM
Apr-05-25 07:42AM
Apr-04-25 04:32PM
12:03PM
Apr-03-25 02:43PM
01:15PM
10:29AM
Apr-02-25 11:09AM
Apr-01-25 01:23PM
12:41PM
Mar-31-25 09:57AM
09:45AM
09:45AM
09:40AM
05:01AM
02:02AM
Mar-29-25 10:05AM
Mar-28-25 01:41PM
08:37AM
Mar-27-25 04:14PM
11:34AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Newcomb George A.Chief Accounting OfficerFeb 18 '25Sale92.542,000185,0807,462Feb 19 04:07 PM
Rott RolandCEO, ImagingNov 05 '24Option Exercise40.4013,275536,31037,573Nov 06 05:53 PM
Rott RolandCEO, ImagingNov 06 '24Sale86.483,577309,33924,298Nov 06 05:53 PM
Roland RottOfficerNov 06 '24Proposed Sale86.483,577309,330Nov 06 05:45 PM
Philip RackliffeOfficerNov 05 '24Proposed Sale87.6390078,870Nov 05 05:22 PM
Rackliffe PhilipCEO, AVSNov 05 '24Sale87.6390078,86712,715Nov 05 04:06 PM
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.Aug 14 '24Sale83.2219,0081,581,84638,541Aug 15 04:45 PM
Kenneth StacherskiOfficerAug 14 '24Proposed Sale82.7419,0081,572,774Aug 14 05:57 PM
Jan MakelaOfficerAug 12 '24Proposed Sale83.2033,0962,753,587Aug 12 04:58 PM
Westrick Thomas J.CEO, Patient Care SolutionsAug 07 '24Sale80.782,750222,14517,509Aug 07 06:18 PM
Thomas WestrickOfficerAug 07 '24Proposed Sale80.782,750222,146Aug 07 05:30 PM